VHIO is the first Spanish site to conduct CAR T cell trial against lymphoma in Europe

(Vall d'Hebron Institute of Oncology) Launched: First international clinical trial with CAR T cell therapy for patients with aggressive B-cell non-Hodgkin lymphoma (B-Cell NHL) in Europe.The trial has been designed to determine the efficacy and safety of JCAR017, a chimeric antigen receptor (CAR) T cell therapy, in the treatment of clinically selected adult patients with relapsed or refractory disease
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news